TITLE

Inhibitory effects of 405 nm irradiation on Chlamydia trachomatis growth and characterization of the ensuing inflammatory response in HeLa cells

AUTHOR(S)
Wasson, Cassandra J.; Zourelias, Jessica L.; Aardsma, Nathan A.; Eells, Janis T.; Ganger, Mike T.; Schober, Justine M.; Skwor, Troy A.
PUB. DATE
January 2012
SOURCE
BMC Microbiology;2012, Vol. 12 Issue 1, p176
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Chlamydia trachomatis is an intracellular bacterium that resides in the conjunctival and reproductive tract mucosae and is responsible for an array of acute and chronic diseases. A percentage of these infections persist even after use of antibiotics, suggesting the need for alternative treatments. Previous studies have demonstrated anti-bacterial effects using different wavelengths of visible light at varying energy densities, though only against extracellular bacteria. We investigated the effects of visible light (405 and 670 nm) irradiation via light emitting diode (LEDs) on chlamydial growth in endocervical epithelial cells, HeLa, during active and penicillin-induced persistent infections. Furthermore, we analyzed the effect of this photo treatment on the ensuing secretion of IL-6 and CCL2, two pro-inflammatory cytokines that have previously been identified as immunopathologic components associated with trichiasis in vivo. Results: C. trachomatis-infected HeLa cells were treated with 405 or 670 nm irradiation at varying energy densities (0 -- 20 J/cm2). Bacterial growth was assessed by quantitative real-time PCR analyzing the 16S: GAPDH ratio, while cell-free supernatants were examined for IL-6 and monocyte chemoattractant protein-1 (CCL2) production. Our results demonstrated a significant dose-dependent inhibitory effect on chlamydial growth during both active and persistent infections following 405 nm irradiation. Diminished bacterial load corresponded to lower IL-6 concentrations, but was not related to CCL2 levels. In vitro modeling of a persistent C. trachomatis infection induced by penicillin demonstrated significantly elevated IL-6 levels compared to C. trachomatis infection alone, though 405 nm irradiation had a minimal effect on this production. Conclusion: Together these results identify novel inhibitory effects of 405 nm violet light on the bacterial growth of intracellular bacterium C. trachomatis in vitro, which also coincides with diminished levels of the pro-inflammatory cytokine IL-6.
ACCESSION #
82320046

 

Related Articles

  • Apoptotic effect on HeLa Cells produced by Chlamydia trachomatis-LPS. Mill�n-Mendoza, Beatriz; Hakimi, Hamid; Eley, Adrian // Revista Kasmera;ene-jun2007, Vol. 35 Issue 1, p7 

    The interaction between the lipopolysaccharide (LPS) of Chlamydia trachomatis and mammalian cells is still largely unknown. Chlamydia trachomatis is an obligate intracellular bacterium responsible for several diseases in humans and animals. In this work, thanks to the isolation of the...

  • Treatment of Chlamydia trachomatis Infections in Pregnant Women. Miller, J.M.; Martin, D.H. // Drugs;Sep2000, Vol. 60 Issue 3, p597 

    The intent of this article is to provide an overview of the epidemiology and pharmacotherapy, including cost analyses, of Chlamydia trachomatis infections in pregnant women. Chlamydia is a common sexually transmitted infection. For pregnant women, there are concerns both for the mother...

  • Evaluation of Antimicrobial Resistance and Treatment Failures for Chlamydia trachomatis: A Meeting Report. Wang, Susan A.; Papp, John R.; Stamm, Walter E.; Peeling, Rosanna W.; Martin, David H.; Holmes, King K. // Journal of Infectious Diseases;3/15/2005, Vol. 191 Issue 6, p917 

    Each year, Chlamydia trachoma tis causes 1%#3 mfflion new infections and results in more than $1 bfflion in medical costs in the United States. Repeat or persistent infection occurs in 10%-15% of women who are treated for C. trachoma tis infection. However, the role played by antimicrobial...

  • The protease inhibitor JO146 demonstrates a critical role for CtHtrA for Chlamydia trachomatis reversion from penicillin persistence. Ong, Vanissa A.; Marsh, James W.; Lawrence, Amba; Allan, John A.; Timms, Peter; Huston, Wilhelmina M. // Frontiers in Cellular & Infection Microbiology;Dec2013, Vol. 3 Issue 12, p1 

    The Chlamydia trachomatis serine protease HtrA (CtHtrA) has recently been demonstrated to be essential during the replicative phase of the chlamydial developmental cycle. A chemical inhibition strategy (serine protease inhibitor JO146) was used to demonstrate this essential role and it was found...

  • Therapy of Cervical Chlamydial Infection. Brunham, Robert C.; Cho-Chou Kuo; Stevens, Claire E.; Holmes, King K. // Annals of Internal Medicine;Aug82, Vol. 97 Issue 2, p216 

    Presents a study that evaluated the treatment of cervical Chlamydia trachomatis infection in nonpregnant women. Assessment of the clinical response of cervicitis to tetracycline hydrochloride; Analysis of the microbiologic response to antimicrobial therapy; Assessment of the adverse effects of...

  • A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol. Hocking, Jane S.; Vodstrcil1,2, Lenka A.; Huston, Wilhelmina M.; Timms, Peter; Chen, Marcus Y.; Worthington, Karen; McIver, Ruthy; Tabrizi, Sepehr N. // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: Chlamydia trachomatis is the most commonly diagnosed bacterial sexually transmitted infection in the developed world and diagnosis rates have increased dramatically over the last decade. Repeat infections of chlamydia are very common and may represent re-infection from an untreated...

  • Neonatal Chlamydial Infections: Prevention and Treatment. Zar, Heather J. // Pediatric Drugs;2005, Vol. 7 Issue 2, p103 

    Neonatal chlamydial infection, which manifests principally as ophthalmia neonatorum (ON) or pneumonia, is a significant cause of neonatal morbidity. Widespread use of silver nitrate drops resulted in a dramatic decline in the incidence of gonococcal ophthalmia but had much less impact on the...

  • Doxycycline failure in lymphogranuloma venereum. Méchaï, Frédéric; De Barbeyrac, Bertille; Aoun, Olivier; Mérens, Audrey; Imbert, Patrick; Rapp, Christophe // Sexually Transmitted Infections;Aug2010, Vol. 86 Issue 4, p9 

    Lymphogranuloma venereum (LGV) cases are currently re-emerging in the homosexual community, particularly in HIV-seropositive patients. The standard treatment for this infection, which is caused by Chlamydia trachomatis L1, L2 and L3 serotypes, is a 3-week doxycycline regimen. The case is...

  • Chlamydia trachomatis Exposure in Newborns. Miller, Karl E. // American Family Physician;2/1/2004, Vol. 69 Issue 3, p727 

    Discusses the study "Oral Erythromycin Prophylaxis vs Watchful Waiting in Caring for Newborns Exposed to Chlamydia trachomatis," by M.B. Rosenman et al., from the June 2003 issue of the journal "Archives of Pediatrics and Adolescent Medicine."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics